Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Primer on integrative oncology.

Lawrence B Berk1

  • 1Newark Radiation Oncology, 115 McMillen Drive, Newark, OH 43055, USA. lbberk@cancertherapy.us

Hematology/Oncology Clinics of North America
|April 4, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Randomized phase III trial to evaluate radiopharmaceuticals and zoledronic acid in the palliation of osteoblastic metastases from lung, breast, and prostate cancer: report of the NRG Oncology RTOG 0517 trial.

Annals of nuclear medicine·2018
Same author

A Randomized Phase 2 Trial of Prophylactic Manuka Honey for the Reduction of Chemoradiation Therapy-Induced Esophagitis During the Treatment of Lung Cancer: Results of NRG Oncology RTOG 1012.

International journal of radiation oncology, biology, physics·2017
Same author

Significance of Co-expression of Epidermal Growth Factor Receptor and Ki67 on Clinical Outcome in Patients With Anal Cancer Treated With Chemoradiotherapy: An Analysis of NRG Oncology RTOG 9811.

International journal of radiation oncology, biology, physics·2017
Same author

Utility of the ACE Inhibitor Captopril in Mitigating Radiation-associated Pulmonary Toxicity in Lung Cancer: Results From NRG Oncology RTOG 0123.

American journal of clinical oncology·2016
Same author

RTOG 0631 phase 2/3 study of image guided stereotactic radiosurgery for localized (1-3) spine metastases: phase 2 results.

Practical radiation oncology·2014
Same author

The impact of concurrent granulocyte-macrophage colony-stimulating factor on quality of life in head and neck cancer patients: results of the randomized, placebo-controlled Radiation Therapy Oncology Group 9901 trial.

Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation·2014

Designing studies for integrative cancer medicine faces challenges. Oncologists need to guide patients toward evidence-based complementary therapies when conventional treatments are insufficient.

Area of Science:

  • Oncology
  • Integrative Medicine
  • Cancer Research

Background:

  • Integrative medicine offers complementary therapies for cancer patients.
  • Standard cancer treatments can be insufficient, leading patients to seek alternatives.
  • Current research faces significant design difficulties in evaluating these techniques.

Purpose of the Study:

  • To highlight the challenges in designing clinical trials for integrative cancer medicine.
  • To emphasize the need for oncologists to understand and guide patients on alternative treatments.

Main Methods:

  • This study reviews the current challenges in designing clinical trials for integrative cancer techniques.
  • It analyzes the reasons for patient inclination towards alternative therapies.

Related Experiment Videos

Main Results:

  • There are significant design difficulties in evaluating integrative cancer medicine efficacy.
  • Patients increasingly seek alternative treatments when standard care fails.

Conclusions:

  • Overcoming design challenges is crucial for determining the efficacy of integrative cancer techniques.
  • Oncologists must be knowledgeable about alternative medical agents and techniques to guide patients effectively.